Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0738
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling ; volume:95 ; number:9 ; day:15 ; month:7 ; year:2021 ; pages:3015-3029 ; date:9.2021
Archives of toxicology ; 95, Heft 9 (15.7.2021), 3015-3029, 9.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00204-021-03115-y
- URN
-
urn:nbn:de:101:1-2021110720221921093245
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Verscheijden, Laurens F. M.
- Koenderink, Jan J.
- Wildt, Saskia N. de
- Russel, Frans G. M.
- SpringerLink (Online service)
Other Objects (12)
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids